Abstract
• But: empecher l'evolution de l'hepatite chronique vers la cirrhose et le carcinome hepatocellulaire. • Traitement medicamenteux actuel: interferon alpha. • Efficacite: suppression de la replication virale chez 40% des sujets traites pendant 4 mois. • Controle de l'efficacite: conversion serologique (disparition AgHBe et apparition anti-HBe) et negativation de l'ADN viral dans le sang. • Des protocoles de traitement associant plusieurs medicaments antiviraux sont a l'etude.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
